Further, we demonstrated the role of intracellular S1P in MM survival by manipulating the S1P level in several ways: specific SphK1 inhibition, S1P extracellular transport blockade, SphK1 activity stimulation, and inhibition of intracellular irreversible S1P degradation. The gene discussed is SPHK1; the disease is Miyoshi myopathy.